Halopemide

This classification denotes an antipsychotic agent with the molecular formula C21H22ClFN4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 65Q28TV0ZY, chemically known as r 34,301 but generally known as halopemide, which bears US NIH Compound Identifier 65490. European Medicines Agency schedules Halopemide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08003MIG. The term HALOPEMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). HALOPEMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule halopemide under HS 29333999 and SITC 51574. As of Q4 2014, HALOPEMIDE remains the US FDA Preferred Term for this commodity. Halopemide bears US NLM identifiers UMLS ID C0062101 and NCI Concept Code C65840. SMILES: CLC1CC2[NH]C(=O)N(C3CCN(CC3)CCNC(=O)C3CCC(F)CC3)C2CC1.